About 3 results found for searched term "Enfortumab" (1.103 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21436 | Enfortumab (anti-Nectin-4) | Apoptosis |
| Enfortumab anti-Nectin-4 is a monoclonal antibody targeting Nectin-4 that acts as an ADC to initiate the internalization of the ADc-Nectin-4 complex and the hydrolyzed cleavage of Monomethylaustatin E (MMAE), The microtubule network was damaged to induce apoptosis. Enfortumab anti-Nectin-4 can be used to study urothelial cancer. | ||
| M24619 | Enfortumab vedotin-ejfv | Antibody-Drug Conjugates (ADCs) |
| Enfortumab vedotin-ejfv is an anti-Nectin-4 antibody-drug conjugate (ADC) for the management of urothelial carcinoma. Enfortumab vedotin-ejfv is a fully humanized IgG1 antibody conjugated to the microtubule disrupting agent MMAE via a protease-cleavable maleimidocaproylvaline-citrulline linker. | ||
| M24685 | Enfortumab | Others |
| Enfortumab is a monoclonal antibody targeting Nectin-4. Enfortumab can used for researching urothelial cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
